Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Mirum Pharmaceuticals (MIRM) Q2 2026 Earnings
MIRM
6
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-13.43
-8.94
-4.44
0.05
Details
Expected EPS
-0.365267
Actual EPS
-13.43
Surprise EPS
-13.06
Surprise Percent
+3,576.76%
Description
Mirum Pharmaceuticals (MIRM) has reported earnings of -13.43 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login